New York, NY, August 08, 2011 --(PR.com
)-- ABR Investment Strategy (ABR) announced today the formation of ABR-Healthco. ABR-Healthco will serve as ABR Investment Strategy's Healthcare research division.
ABR-Healthco will be run by Manoj Garg, who has over 10 year's experience in Healthcare research. The creation of ABR-Healthco brings another important vertical to complement ABR’s existing research coverage in the Technology, Media and Telecom sectors.
“This is a perfect fit in terms of people and product. Both Rob Sanderson and I have extensive experience working with Manoj and know what he and his team can do. Manoj launched Healthcare research at American Technology Research where the three of us worked together,” said Brad Gastwirth Executive Managing Director and Co-Founder of ABR Investment Strategy. “There continues to be a need for unbiased and value-added research. We founded ABR to become the best independent investment advisor serving institutional clients. In roughly two years we believe we have built a better research product, delivery model and level of service well beyond that of the traditional Sell Side," said Gastwirth.
"I am very excited to expand our research focus, adding an important sector like Healthcare and to partner with a professional like Manoj Garg," said Rob Sanderson Director of Research and Co-Founder of ABR. "I've had the pleasure of working closely with Manoj in the past and know he is a sound analytical thinker, not afraid to challenge consensus and holds integrity with the highest regard. These are the hallmarks on which we've built our firm and believe Manoj and the team he is building will be a great complement to our product and core values."
Manoj Garg added, “I am excited to be working with Brad and Rob again, and even more so looking forward to adding upon the impressive ABR franchise that they are continuing to build to deliver unbiased, proprietary investment research. Healthcare continues to represent not only a significant part of the US investment dollars, but one that offers significant stock dislocations and opportunities for growth that investors can benefit from. Our primary purpose has been, and will remain, identifying those dislocations and growth opportunities.”
Mr. Garg most recently ran a top rated Healthcare team at Soleil Securities (recently purchased by Ticonderoga) and is known for providing sound investment advice in the Pharmaceutical and Biotech fields.
About ABR Investment Strategy: ABR Investment Strategy LLC was formed to become the leading independent investment advisory firm focusing on growth companies. With the ever-changing environment and growing need for truly unbiased and proprietary research, ABR plans to leverage its experience and bring valuable inputs to its buy side partners. We have structured our firm to avoid the many conflicts and issues we've observed working at several broker/dealers, both bulge and boutique.
For more about ABR Investment Strategy please contact email@example.com